GlassScriptPhysician profile
John S Lam
NPI 1417975608
$5,006.64
in general payments reported to CMS, 2019-2025
15 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2021: $208 · 2022: $570 · 2023: $444 · 2024: $2,088 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,544 · Travel and Lodging: $1,165 · Consulting Fee: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.38 |
| Travel and Lodging | $1,165.40 |
| Consulting Fee | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $1,100.00 | 2024-2025 | |
| Profound Medical Corp. | $779.94 | 2024 | Tulsa-Pro |
| Pfizer INC. | $548.26 | 2024 | |
| Cook Medical LLC | $517.25 | 2021-2025 | Resonance, Cook, Fiber Dust |
| Urogen Pharma, INC. | $416.88 | 2022-2025 | |
| Koelis INC. | $320.88 | 2023 | |
| Astellas Pharma US INC | $268.05 | 2019-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $255.89 | 2019-2022 | |
| Coloplast Corp | $204.66 | 2025 | |
| Medtronic USA, INC. | $175.61 | 2019 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Ethicon Endo-Surgery INC. | $100.00 | 2022 | |
| Intuitive Surgical, INC. | $100.00 | 2022 | |
| Axogen | $66.07 | 2025 | |
| Teleflex LLC | $15.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.